COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

30,741 Articles (22,502 medRxiv, 8,239 bioRxiv)

Most recent first Previous |  Page 1127: Articles 11261-11270  | Next

Time-varying effectiveness of the mRNA-1273, BNT162b2 and Ad26.COV2.S vaccines against SARS-CoV-2 infections and COVID-19 hospitalizations and deaths: an analysis based on observational data from Puerto Rico
Robles-Fontan, M. M., Nieves, E. G., Cardona-Gerena, I., Irizarry, R. A.
10.1101/2021.10.17.21265101 — Posted: 2021-10-18
The usefulness of antigen testing in predicting contagiousness in COVID-19
Lopera, T. J., Diaz, F. J., Alzate-Angel, J. C., Rugeles, M. T., Aguilar-Jimenez, W.
10.1101/2021.10.16.21265067 — Posted: 2021-10-18
Reduced seroconversion in children compared to adults with mild COVID-19
Toh, Z. Q., Anderson, J., Mazarakis, N., Neeland, M., Higgins, R. A., Rautenbacher, K., Dohle, K., Nguyen, J., Overmars, I., Donato, C., Sarkar, S., Clifford, V., Daley, A., Nicholson, S., Mordant, F. L., Subbarao, K., Burgner, D., Curtis, N., Bines, J. E., McNab, S., Steer, A. C., Mulholland, K., Tosif, S., Crawford, N. W., Pellicci, D. G., Do, L. A. H., Licciardi, P.
10.1101/2021.10.17.21265121 — Posted: 2021-10-18
Meta-analysis of coagulation disbalances in COVID-19: 41 studies and 17601 patients
Len, P., Iskakova, G., Sautbayeva, Z., Kussanova, A., Tauekelova, A. T., Sugralimova, M. M., Dautbayeva, A. S., Abdiyeva, M. M., Ponomarev, E. D., Bekbossynova, M. S., Barteneva, N. S.
10.1101/2021.10.17.21265108 — Posted: 2021-10-18
Self-reported safety of the BBIBP-CorV (Sinopharm) COVID-19 vaccine among Iranian people with multiple sclerosis
Etemadifar, M., Abhari, A. P., Nouri, H., Akhavan Sigari, A., Piran Daliyeh, S. M., Maracy, M. R., Salari, M., Maleki, S., Sedaghat, N.
10.1101/2021.10.17.21265114 — Posted: 2021-10-18
Public Perception of COVID-19 Vaccines on Twitter in the United States
Xie, Z., Wang, X., Jiang, Y., Chen, Y., Huang, S., Ma, H., Anand, A., Li, D.
10.1101/2021.10.16.21265097 — Posted: 2021-10-18
Long-term predictions of humoral immunity after two doses of BNT162b2 and mRNA-1273 vaccines based on dosage, age and sex
Korosec, C. S., farhangsardroodi, s. S., Dick, D. W., Gholami, S., Ghaemi, M. S., Moyles, I. R., Craig, M., Ooi, H. K., Heffernan, J. M.
10.1101/2021.10.13.21264957 — Posted: 2021-10-18
COVID-19 is associated with higher risk of venous thrombosis, but not arterial thrombosis, compared with influenza: Insights from a large US cohort
Ward, A., Sarraju, A., Lee, D., Bhasin, K., Gad, S., Beetel, R., Chang, S., Bonafede, M., Rodriguez, F., Dash, R.
10.1101/2021.10.15.21264137 — Posted: 2021-10-18
Durability of antibody responses and frequency of clinical and subclinical SARS-CoV-2 infection six months after BNT162b2 COVID-19 vaccination in healthcare workers
Laing, E. D., Weiss, C. D., Samuels, E. C., Coggins, S. A., Wang, W., Wang, R., Vassell, R., Sterling, S. L., Tso, M. A., Conner, T., Goguet, E., Jackson-Thompson, B. M., Illinik, L., Davies, J., Ortega, O., Parmelee, E., Hollis-Perry, M., Maiolatesi, S. E., Wang, G., Ramsey, K. F., Reyes, A. E., Alcorta, Y., Wong, M. A., Lindrose, A. R., Duplessis, C. A., Tribble, D. R., Malloy, A. M., Burgess, T. H., Pollett, S. D., Olsen, C. H., Broder, C. C., Mitre, E.
10.1101/2021.10.16.21265087 — Posted: 2021-10-18
Factors associated with severity of COVID-19 disease in a multicenter cohort of people with HIV in the United States, March-December 2020
Shapiro, A. E., Bender Ignacio, R. A., Whitney, B. M., Delaney, J. C., Nance, R. M., Bamford, L., Wooten, D., Keruly, J. C., Burkholder, G., Napravnik, S., Mayer, K. H., Webel, A. R., Kim, H. N., Van Rompaey, S., Christopoulos, K., Jacobson, J., Karris, M., Smith, D., Johnson, M. O., Willig, A., Eron, J. J., Hunt, P., Moore, R. D., Saag, M. S., Mathews, W. C., Crane, H. M., Cachay, E. R., Kitahata, M. M.
10.1101/2021.10.15.21265063 — Posted: 2021-10-18

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).